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Abstract
Introduction:  Colonic  self-expandable  metal  stent  placement  is  widely  used  for  palliation  of
obstructive  colorectal  cancer.  The  European  recommendations  for  stent  placement  as  a  bridge
to elective  surgery  in  obstructive  colorectal  cancer  were  recently  reviewed.  The  aim  of  this
study was  to  evaluate  the  efﬁcacy  and  safety  of  stent  placement  in  obstructive  colorectal  cancer
and to  discuss  these  recent  guidelines.
Materials  and  methods:  Demographic  characteristics,  procedure  indications,  complications
and ﬁnal  outcome  in  patients  with  obstructive  colorectal  cancer  who  underwent  endoscopic
stent placement  between  January  2012  and  June  2015  were  retrospectively  analyzed.  Statistical
analysis was  performed  with  SPSS  V22.
Results:  Thirty-six  patients  were  included,  20  (56%)  women,  mean  age  70.6  ±  10.9  years.  Stent
placement  as  a  bridge  to  elective  surgery  was  performed  in  75%  (n  =  27)  of  patients  and  with
palliation  intent  in  25%  (n  =  9).  In  94%  (n  =  34)  of  procedures,  technical  and  clinical  success
was achieved.  A  total  of  eleven  (11%)  complications  were  observed:  2  migrations  and  9  per-
forations. No  procedure  related  death  was  recorded.  When  stents  were  placed  as  a  bridge  to
surgery, average  time  between  endoscopic  procedure  and  surgery  was  11.7  ±  9.4  days  (exclud-
ing three  patients  who  underwent  neoadjuvant  chemotherapy).  Six  perforations  were  recorded
in this  group:  one  overt  and  ﬁve  silent  (three  during  surgery  and  two  after  histopathological
examination  of  the  resected  specimen).  Twenty-one  patients  underwent  adjuvant  chemother-
apy. During  the  follow-up  period  of  14.7  ±  10.9  months  recurrence  was  observed  in  ﬁve  patients.
None of  the  recurrence  occurred  in  the  group  of  patients  with  perforation.∗ Corresponding author.
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Conclusions:  In  this  study,  stent  placement  was  an  effective  procedure  in  obstructive  colorectal
cancer. It  was  mainly  used  as  a  bridge  to  elective  surgery.  However,  a  signiﬁcant  rate  of  silent
perforation  was  observed,  which  may  compromise  the  oncological  outcome  of  these  potentially
curable patients.  Prospective  real  life  studies  are  warranted  for  a  better  deﬁnition  of  actual
recommendations.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Resumo
Introduc¸ão:  A  colocac¸ão  de  próteses  metálicas  autoexpansíveis  é  um  procedimento  endoscópico
amplamente  realizado  como  tratamento  paliativo  do  cancro  colo-rectal.  As  recomendac¸ões
europeias  para  a  colocac¸ão  de  prótese  como  ponte  para  a  cirurgia  na  obstruc¸ão  por  cancro  colo-
rectal foram  revistas  recentemente.  O  objetivo  deste  estudo  foi  avaliar  a  eﬁcácia  e  seguranc¸a
da colocac¸ão  de  próteses  na  obstruc¸ão  maligna  por  cancro  colo-rectal  e  discutir  as  últimas
recomendac¸ões publicadas.
Materiais  e  métodos:  Análise  retrospectiva  das  características  demográﬁcas,  indicac¸ões,
complicac¸ões e  resultados  da  colocac¸ão  de  próteses  metálicas  autoexpansíveis  em  doentes
com cancro  colo-rectal  obstrutivo  entre  janeiro  de  2012  e  junho  de  2015.  A  análise  estatística
foi realizada  com  SPSS  V22.
Resultados:  Foram  incluídos  36  doentes,  20  (56%)  do  sexo  feminino,  com  idade  média  de
70.6 ±  10.9  anos.  As  próteses  foram  colocadas  como  ponte  para  cirurgia  em  75%  (n  =  27)  dos  casos
e com  intuito  paliativo  em  25%  (n  =  9).  Em  94%  (n  =  34)  dos  procedimentos  obteve-se  sucesso  téc-
nico e  clínico.  No  total  registaram-se  11  (31%)  complicac¸ões:  2  migrac¸ões  e  9  perfurac¸ões.  Não
se registou  mortalidade  associada  ao  procedimento.  Nos  casos  como  ponte  para  a  cirurgia,  o
tempo médio  entre  o  procedimento  endoscópico  e  a  cirurgia  foi  de  11.7  ±  9.4  dias  (excluí-
dos três  doentes  submetidos  a  quimioterapia  neoadjuvante).  Observaram-se  seis  perfurac¸ões
neste grupo  de  doentes:  uma  perfurac¸ão  clínica  e  cinco  silenciosas  (três  intra-operatoriamente
e duas  após  avaliac¸ão  anatomopatológica  da  pec¸a  operatória).  Vinte  e  um  doentes  foram  sub-
metidos a  quimioterapia  adjuvante.  Após  um  tempo  médio  de  seguimento  de  14.7  ±  10.9  meses,
registaram-se  cinco  casos  de  recorrência.  Nenhum  dos  casos  de  recorrência  ocorreu  no  grupo
de doentes  com  perfurac¸ão.
Conclusões:  Nesta  amostra,  a  colocac¸ão  de  prótese  revelou-se  um  procedimento  endoscópico
eﬁcaz.  Na  maioria  dos  doentes  foi  utilizada  como  ponte  para  a  cirurgia.  No  entanto,  veriﬁcou-se
uma taxa  signiﬁcativa  de  perfurac¸ão  silenciosa  que  poderá  comprometer  o  resultado  oncológico
de doentes  tratados  com  intuito  curativo.  Estudos  prospetivos  da  prática  real  podem  ser  úteis
para uma  melhor  deﬁnic¸ão  das  recomendac¸ões  atuais.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este
e´ um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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s. Introduction
olorectal  cancer  (CRC)  is  the  third  most  common  cancer
n  males  and  the  second  in  females  worldwide.1 Malignant
arge  bowel  obstruction  is  reported  in  up  to  20%  of  colonic
ancer  patients.2 The  management  of  this  severe  clinical
ondition  remains  controversial.3
Malignant  colonic  obstruction  may  be  managed  by  emer-
ent  surgery  with  resection  and/or  diversion  procedures
r  by  endoscopy  with  self-expanding  metal  stents  (SEMS)
lacement.4
In  the  latest  European  Society  of  Gastrointestinal
ndoscopy  (ESGE)  guidelines  published  in  2014,  SEMS
s
s
olacement  is  recommended  as  the  preferred  treat-
ent  for  palliation  of  malignant  and  metastatic  colonic
bstruction3,5,6 but  the  role  of  SEMS  as  a  bridge  to  elective
urgery  in  obstructive  CRC  was  largely  modiﬁed.3 Preopera-
ive  SEMS  placement  can  prevent  high-risk  emergent  surgery
llowing  patient  stabilization  and  staging  workup  before
urgical  intervention.7,8 This  approach  showed  more  favor-
ble  short-term  outcomes  in  terms  of  permanent  stoma
ormation,  primary  anastomosis  and  overall  morbidity  and
imilar  postoperative  mortality  when  compared  to  emergent
urgery.9--11 However,  a  Dutch  multicentric  randomized  trial
howed  an  increased  morbidity  and  mortality  in  the  group
f  patients  with  SEMS  as  bridge  to  surgery  when  compared
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to  the  surgical  approach  and  due  to  these  interim  results
the  study  was  interrupted.12 This  study  was  criticized  by
several  authors  who  questioned  study  design  and  mainly
the  experience  of  some  of  the  centers  in  the  use  of  metal
stents  due  to  the  low  clinical  and  endoscopic  success  rate
reported.
Even  if  short-term  beneﬁts  of  stent  placement  are
unquestionable,  oncological  outcomes  are  yet  undeter-
mined  since  SEMS  insertion  may  promote  tumor  progression
and  metastasis.3,13,14 A  meta-analysis  recently  published  by
Erichsen  et  al.15 reported  a  5-year  recurrence  risk  of  39%
after  SEMS  placement  compared  with  30%  after  urgent  resec-
tion.  Although  not  completely  proven,  some  studies  have
shown  an  association  between  recurrence  and  stent  related
perforation.14 Even  silent  perforations  detected  only  on  the
surgical  specimen  may  have  oncological  impact,  potentially
resulting  in  tumor  cell  seeding  and  dissemination.9 Sabbagh
et  al.16 reported  higher  rates  of  tumor  ulceration,  perineural
and  lymph  node  invasion  after  stent  placement,  suggesting
that  these  microscopic  alterations  may  also  account  for  a
worse  oncological  outcome  in  these  groups  of  patients.
Therefore  recent  ESGE  guidelines  published  in  October
2014  no  longer  recommend  colonic  stenting  as  a  bridge
to  surgery  as  standard  treatment.  It  may  be  considered
as  an  acceptable  option  in  patients  with  an  increased
risk  of  postoperative  mortality  (over  the  age  of  70  years
and/or  American  Society  of  Anesthesiologists  (ASA)  score
of  ≥3)  since  the  potentially  impaired  oncological  outcome
associated  to  stent-related  perforation  does  not  seem  to
outweigh  the  risk  of  postoperative  death.3,11,14 These  rec-
ommendations  were  felt  to  be  very  conservative  by  most
gastroenterologists.
The  aim  of  the  present  study  was  to  critically  evaluate
the  efﬁcacy  and  safety  of  SEMS  placement  in  a  retrospective
series  of  patients  with  obstructive  colorectal  cancer  and  to
discuss  current  recommendations  of  this  procedure.
2. Materials and methods
We  conducted  a  retrospective  study  of  all  patients  with
obstructive  CRC  who  underwent  endoscopic  stent  placement
between  January  2012  and  June  2015  in  a  secondary  hospi-
tal,  Hospital  Beatriz  Ângelo,  in  Lisbon  area.  ESGE  guidelines
were  published  in  October  2014  and  we  modiﬁed  our  thera-
peutic  strategy  accordingly,  in  June  2015.
Acute  colorectal  obstruction  was  diagnosed  by  the
absence  of  any  ﬂatus  or  bowel  movements  in  the  pre-
ceding  24  h,  abdominal  distension  and/or  the  presence  of
dilated  colonic  loops  on  abdominal  radiograph.  All  patients
underwent  a  contrast-enhanced  computed  tomography  (CT)
before  endoscopic  procedure  in  order  to  conﬁrm  the  pres-
ence  of  obstruction,  deﬁne  the  level  of  the  stenosis,  exclude
perforation  as  well  as  local  and  distant  staging.
Patient  selection  criteria  for  stenting  were  obstructive
CRC  located  at  or  distal  to  the  splenic  ﬂexure  and  absence
of  clinical  or  imagiologic  evidence  of  perforation.  Age,
general  physical  condition  or  disease  stage  were  not  consid-
ered  exclusion  criteria  for  stenting  as  most  cases  occurred
before  the  publication  of  ESGE  guidelines.  Patients  with
other  causes  of  colonic  obstruction  were  excluded  from  the
study.
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Stents  were  inserted  as  a  bridge  to  elective  surgery  or
ith  palliation  intent.  In  our  study,  bridge  to  surgery  was
eﬁned  as  elective  surgery  after  optimization  of  physio-
ogical  parameters  and  recovery  of  normal  bowel  function,
egardless  of  the  length  of  time  between  SEMS  insertion  and
urgery.
All  colonic  SEMS  were  inserted  endoscopically  under
uoroscopic  guidance  with  sedation  performed  mainly  by
nesthesiologist.  Biopsies  of  the  tumor  were  obtained  in
ase  of  previously  unknown  diagnosis.  SEMS  placement
as  performed  using  through-the-scope/over  the  guidewire
echnique.  After  reaching  the  stenosis,  a  standard  biliary
annula  or  stone  extraction  balloon  with  a  0.035  in.  Hydra
agwireTM Guidewire  (Boston  Scientiﬁc)  was  advanced.  Soon
fter  it  overcame  the  stenosis  full  strength  contrast  was
njected  under  ﬂuoroscopic  guidance.  The  extent  of  the
tenosis  was  measured  with  the  stone  extraction  balloon
r  estimate  through  ﬂuoroscopy.  Clips  were  used  as  ﬂu-
roscopic  markers  to  identify  stenosis  distal  ends.  Under
ndoscopic  and  ﬂuoroscopic  guidance,  the  stents  were  posi-
ioned  above  the  stricture  and  proximally  deployed.  Stent
ength  ranged  from  6  cm  to  10  cm  and  was  inserted  to  include
t  least  2  cm  on  each  side  of  the  lesion.  After  deploy-
ent  its  correct  position  was  conﬁrmed  with  ﬂuoroscopic
mages.  Uncovered  colonic  stents  with  proximal  release
ystem  (Boston  Scientiﬁc  --  WallFlex® or  Cook  Medical  --
volution®) were  used  in  all  patients.  Balloon  dilatation  was
ot  performed  in  any  patients  either  before  or  after  SEMS
nsertion.  Abdominal  radiographs  were  taken  afterwards  to
heck  full  deployment  of  the  stent  and  colonic  decompres-
ion.
After  resolution  of  obstruction,  pre-operative  staging  was
ompleted  and  patients  with  potentially  curable  disease
ere  offered  elective  resection.  Neoadjuvant  and/or  adju-
ant  chemotherapy  were  performed  whenever  indicated.
hose  with  incurable  disease  were  referred  for  considera-
ion  of  palliative  chemotherapy  according  to  international
uidelines.4
Data  collected  included  patient  demographics,  endo-
copic  ﬁndings  (tumor  anatomical  site  and  length),  local
nd  distant  staging,  technical  and  clinical  success,  stent-
elated  complications  and  mortality  as  well  as  details  of
urther  interventions  performed  after  stenting  (such  as  stent
einsertion,  surgery  or  chemotherapy).  For  those  patients
ith  endoscopic  stent  placement  as  a  bridge  to  surgery  we
lso  recorded  time  to  surgery,  perforations  observed  during
urgery  and  on  the  surgical  specimen  as  well  as  recurrence
ate.
Technical  success  was  deﬁned  as  successful  stent  deploy-
ent  across  the  obstructing  tumor  with  radiographic
onﬁrmation  of  ﬂaring  of  the  stent  both  proximally  and  dis-
ally.  Clinical  success  was  deﬁned  as  colonic  decompression
ith  visible  ﬂatus  or  stool  passage  within  48  h  after  the  pro-
edure.
Stent  complications  were  deﬁned  as  those  leading  to  new
ymptoms,  characterized  by  perforation,  re-obstruction  and
tent  migration.
Statistical  analysis  was  performed  using  SPSS  V22.0.  All
ontinuous  variables  were  described  as  median  and  range,
hile  categorical  variables  were  expressed  as  frequency  and
ercentage.  To  explore  univariate  associations  in  the  distri-
ution  of  categorical  data,  the  Chi-squared  test  or  Fisher’s
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Table  1  Demographics  and  clinicopathological  parameters  of  all  patients  who  underwent  SEMS  insertion.
Bridge  to  surgery  group  (n  =  27)  Palliation  group  (n  =  9)  p  Total  (n  =  36)
Sex  ratio  (F:M) 17:10  3:6  0.146  20:16
Age (years  ±  SD)  68.2  ±  10.2  77.9  ±  10.1  0.018  70.6  ±  10.9
ASA (n  (%))  0.254
I 1  (4)  0  1  (3)
II 18  (66)  4  (44)  22  (61)
III 7  (26)  4  (44)  11  (31)
IV 1  (4)  1  (11)  2  (6)
Tumor length  (cm  ±  SD)  3.17  ±  0.71  3.3  ±  0.58  3.21  ±  0.66
Tumor location  (n  (%)) 0.293
Rectum-sigmoid 4  (15) 4  (44) 8  (22)
Sigmoid 14  (52) 3  (33) 17  (47)
Descending colon  8  (30)  1  (11)  9  (25)
Splenic ﬂexure  1  (4)  1  (11)  2  (6)
Pathological  stage  (n  (%))  0.011
I 0  0  0
II 10  (37)  1  (11)  11  (31)
III 11  (41)  1  (11)  12  (33)
IV 6  (22)  7  (78)  13  (36)
Tumor differentiation  (n  (%))  0.701
Well 4  (15)  1  (11)  5  (14)
Moderate 22  (81)  6  (67)  28  (78)
Poor 1  (4)  2  (22)  3  (8)
Technical success  (n  (%))  26  (96)  8  (89)  0.443  34  (94)
Clinical success  (n  (%))  26  (96)  8  (89)  0.443  34  (94)
Complications  (n  (%))  0.121
Migration  2  (7)  0  2  (6)
Perforation  (overt  and  silent)  6  (22)  3  (33)  9  (25)
Mortality (n  (%))  5  (19)  5  (56)  0.120  10  (28)
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aFollow-up (months  ±  SD)  14.7  ±  10.9  
xact  test  was  used  as  appropriate.  Differences  in  mean  con-
inuous  variables  between  groups  of  patients  were  analyzed
y  the  t-test.  A  p  value  <  0.05  was  considered  statistically
igniﬁcant.
. Results
tent  placement  was  attempted  in  36  patients,  20  (56%)
omen,  mean  age  70.6  ±  10.9  years.  Twenty-seven  patients
75%)  were  stented  as  a  bridge  to  surgery  and  the  remaining
ine  patients  (25%)  underwent  SEMS  insertion  with  palliative
ntent.  Patient  demographics,  clinical  and  endoscopic  data
f  all  patients  are  summarized  in  Table  1.
Results  for  both  groups  are  shown  and  discussed  sepa-
ately.
.1.  Palliation  group
ine  patients  (25%)  underwent  SEMS  insertion  with  palliative
ntent.Technical  and  clinical  success  was  achieved  in  8  out  of  9
89%)  procedures.  In  the  remaining  case,  the  stent  could  not
vercome  the  stenosis,  probably  related  to  stricture  angu-
ation,  and  the  patient  underwent  urgent  surgery.
b
m
o3  ±  1.7  0.004  11.8  ±  10.7
Three  overt  perforations  were  observed  22.7  ±  6  days
fter  stent  placement,  requiring  urgent  surgery.  No  stent-
elated  death  was  recorded.
Five  patients  underwent  palliative  chemotherapy.  In  the
emaining  four  cases,  patients  performance  status  was  4  and
est  supportive  care  was  decided.  All  patients  with  perfora-
ions  were  receiving  chemotherapy  --  two  with  5-ﬂuouracil
nd  iritnotecan  (and  cetuximab)  and  one  with  capecitabine.
one  of  the  patients  was  treated  with  bevacizumab.
With  a  mean  time  of  follow-up  of  3  ±  1.7  months,  5  out
f  9  patients  (56%)  had  died.
.2.  Bridge  to  surgery  group
wenty-seven  patients  (75%)  had  potentially  curable  disease
n  staging  and  were  stented  as  a  bridge  to  surgery.  Fourteen
atients  were  ≤70  years  and/or  ASA  <  III  (all  treated  before
une  2015)  and  13  were  >70  years  and/or  ASA  ≥  III.
In  96%  (26/27)  of  cases,  technical  and  clinical  success  was
chieved.  In  one  patient  the  stent  did  not  fully  expand  after
eing  correctly  placed  and  the  patient  was  operated.
Eight  stent-related  complications  were  recorded:  two
igrations  and  six  perforations.  One  stent  migration
ccurred  during  the  endoscopic  procedure  and  a  second
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Table  2  Comparison  of  patients  with  stent-related  perforation  and  without  perforation  in  bridge  to  surgery  group.
Perforation  group  (n  =  6)  No  perforation  group  (n  =  20a)  p
Age  (years  ±  SD) 67.5  ±  5.86 68.05  ±  11.42  0.877
ASA <  III  (n)  6  12  0.132
Time to  surgery  (days  ±  SD)  8.3  ±  2.22  12.4  ±  10.14  0.436
Recurrence  (n)  0  4  0.540
Neoadjuvant  chemotherapy  (n)  2  1  0.123
Adjuvant chemotherapy  (n)  6  15  0.540
Mortality (n)  0  5  0.298
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stent  was  inserted.  The  other  stent  migration  occurred  two
days  after  colonoscopy  requiring  surgery.  One  out  of  six
perforations  was  overt  and  occurred  six  days  after  stent
placement  requiring  urgent  surgery.  The  other  ﬁve  perfo-
rations  were  silent:  three  observed  during  open  surgery
and  two  were  recognized  on  the  surgical  specimen  only.  No
procedure-related  death  was  recorded.
Mean  time  between  endoscopic  procedure  and  surgery
was  11.7  ±  9.4  days,  excluding  three  patients  who  under-
went  neoadjuvant  chemotherapy  --  one  patient  to  down-
stage  his  rectal  tumor  and  two  patients  who  had  resectable
synchronous  liver  metastases.  One  patient  refused  surgery
and  was  lost  in  follow-up.
Twenty-one  out  of  26  (81%)  patients  underwent  adjuvant
chemotherapy.  Of  the  remaining  ﬁve  patients,  one  died  11
days  after  surgery,  and  four  did  not  meet  clinical  conditions
to  undergo  chemotherapy.
With  a  mean  follow-up  time  of  14.7  ±  10.9  months,  15%
(4/26)  of  patients  had  recurrence.  One  patient,  who  had
not  received  adjuvant  chemotherapy  due  to  his  poor  clinical
condition,  had  local  recurrence  with  distant  metastasis.  One
other  patient  had  isolated  local  recurrence  and  in  the  other
two  cases  distant  metastasis  were  observed  without  local
recurrence.  All  these  three  patients  had  received  adjuvant
chemotherapy.
During  the  mean  time  of  follow-up  ﬁve  deaths  were
observed:  two  from  medical  causes  (pneumonia  and
chemotherapy  related  complications),  one  secondary  to
septic  shock  after  anastomosis  leakage,  one  from  disease
progression  and  in  the  other  no  direct  cause  was  deter-
mined.
3.2.1.  Perforation  versus  no  perforation
In  the  bridge  to  surgery  group  six  perforations  were
recorded.  There  was  no  statistically  signiﬁcant  differ-
ence  either  in  age  (67.5  ±  5.86  years  vs  68.05  ±  11.42
years,  p  =  0.877)  or  in  ASA  classiﬁcation  <  III  (6/6  vs  12/20,
p  =  0.132)  between  the  group  of  patients  with  stent-related
perforation  when  compared  with  those  without  perforation.
There  was  also  no  difference  between  the  two  groups
in  terms  of  mean  time  between  endoscopic  procedure  and
surgery  (12.4  ±  10.1  days  vs  8.3  ±  2.2  days,  p  =  0.436).All  cases  of  recurrence  and  death  occurred  in  the  group
of  patients  without  perforation.  There  was  no  statistical  dif-
ference  between  the  two  groups  (p  =  0.540  and  p  =  0.298,
respectively).  These  results  are  summarized  in  Table  2.
s
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o.  Discussion
he  management  of  malignant  large  bowel  obstruction  is
hallenging  and  controversial.3 The  European  Society  of
astrointestinal  Endoscopy  (ESGE)  recently  reviewed  the
ndoscopic  approach  of  obstructive  colorectal  cancer  in
rder  to  provide  practical  guidance  regarding  the  use  of
EMS  in  these  patients.3 Accordingly,  the  use  of  surgery  vs
EMS  in  patients  with  distal  obstructive  colorectal  cancer
as  changed  in  our  Hospital  in  June  2015.  In  this  study,  we
ritically  reviewed  our  experience  with  stent  placement  for
alignant  acute  large  bowel  obstruction  before  we  adopted
he  latest  ESGE  guidelines.
Stent  placement  has  been  shown  to  be  an  effec-
ive  procedure  to  manage  obstructive  CRC.8,17--19 A  recent
rospective  multicenter  study  of  513  cases  of  obstruc-
ive  CRC  showed  a  technical  and  clinical  success  superior
o  95%.19 In  our  study,  technical  and  clinical  success
as  achieved  in  94%  (34/36)  of  patients.  Overall  9  (25%)
erforations  were  recorded:  4  (11%)  patients  had  overt  per-
oration  whereas  in  5  (14%)  other  patients  perforation  was
etected  during  surgery  (n  =  3)  and  on  the  surgical  specimen
n  =  2).
According  to  ESGE  guidelines,  in  patients  with  metastatic
bstructive  CRC  SEMS  placement  is  the  preferred  treat-
ent  since  stoma  formation,  early  complications  (<30  days),
ospitalization  and  30-day  mortality  rates  are  lower  after
tent  placement  compared  with  palliative  surgery.5,6 In  our
tudy  25%  patients  underwent  SEMS  insertion  with  palliative
ntent  with  a  technical  success  rate  of  89%,  similar  to  that
eported  in  the  literature.5,6 No  stent-related  migration  was
ecorded.  However,  3  (33%)  perforations  were  registered,
equiring  urgent  surgery.  The  rate  of  perforation  in  patients
ith  incurable  CRC  was  higher  than  described  in  the  liter-
ture  (8  a  10%)5,6 which  might  relate  to  several  patient  or
umor  related  variables  although  the  small  numbers  do  not
llow  any  deﬁnitive  conclusions.
Colonic  stenting  as  a bridge  to  elective  surgery  in  obstruc-
ive  colorectal  cancer  has  been  widely  used  during  the
ast  decade  because  it  can  prevent  high-risk  emergent
urgery  providing  time  for  patient  stabilization,  staging
orkup  and  appropriate  bowel  preparation  before  elec-
ive  surgery.7,8 Several  studies  compared  the  efﬁcacy  and
afety  of  SEMS  insertion  as  a  bridge  to  elective  surgery  vs
mergency  surgery  for  acute  left-sided  malignant  colonic
bstruction.9--11 Recent  meta-analysis  showed  lower  rates
f  permanent  stoma  formation,  higher  rate  of  successful
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cal  outcome  of  patients  with  potentially  curable  disease.
Nevertheless,  in  our  study  all  the  recurrences  occurred  in98  
rimary  anastomosis  and  more  favorable  overall  morbidity,
ith  no  statistically  signiﬁcant  difference  in  the  postoper-
tive  mortality  between  the  two  groups.9--11 Mean  success
ate  of  colonic  stent  placement  in  these  meta-analysis
anges  from  53  to  97%.9--11,20 In  our  study  75%  patients  were
tented  as  a  bridge  to  surgery,  the  large  majority  of  these
ccurring  before  the  publication  of  current  ESGE  guidelines
n  2014.  Technical  and  clinical  successes  of  96%  were  compa-
able  to  those  reported  in  the  literature.
Although  immediate  advantages  of  SEMS  placement  are
ndeniable,  its  impact  on  the  oncological  outcome  of
atients  with  potentially  curable  disease  remains  the  main
rawback.3,13,14 The  literature  regarding  this  issue  is  still
onﬂicting.  The  meta-analysis  by  Matsuda  et  al.21 which
ncluded  11  studies  compared  432  patients  with  SEMS  as  a
ridge  to  surgery  to  704  patients  who  had  emergent  surgery.
oth  groups  had  comparable  recurrence  rates  (31.1%  vs
7.2%,  NS),  5-year  overall  survival  (57.2%  vs  67.1%,  NS),
nd  5-year  disease-free  survival  (48.4%  vs  59%,  NS),  sug-
esting  that  SEMS  as  bridge  to  surgery  could  be  a  promising
lternative  strategy  for  obstructive  colorectal  cancer.  In  a
ecent  study  published  by  Erichsen  et  al.,15 581  patients
nderwent  SEMS  placement  and  3333  patients  were  oper-
ted.  The  authors  reported  a  higher  5-year  recurrence  risk
n  the  SEMS  group  (39%  vs  30%;  adjusted  incidence  rate  ratio
.12,  95%  conﬁdence  interval  [CI]  0.99--1.28),  but  5-year
verall  survival  rate  was  similar  between  the  two  groups
49%  vs  40%;  adjusted  mortality  rate  ratio  0.98,  95%  CI
.90--1.07).  Whether  the  increased  recurrence  rate  in  the
tudy  by  Erichsen  et  al.  may  have  been  inﬂuenced  by  perfo-
ation  is  unclear,  as  these  data  were  not  available.  Moreover,
he  prevalence  of  stent-related  complications  is  likely  to
e  underestimated,  because  subclinical  perforations  may  be
dentiﬁed  only  after  histological  examination  of  the  surgical
pecimen.
The  meta-analysis  by  Tan  et  al.9 reported  a  clinical  per-
oration  rate  of  6.9%  and  silent  perforation  rate  of  14%
fter  stent  placement  as  a  bridge  to  elective  surgery.  In
ur  study,  stent-related  perforation  occurred  in  6  (22.2%)
atients  in  the  bridge  to  surgery  group.  One  perforation  was
vert  (3.7%)  and  5  perforations  were  silent  (18.5%):  3  (11.1%)
ere  diagnosed  during  surgery  and  2  (7.4%)  were  seen  only
n  histopathological  examination  of  the  resected  specimen.
hus,  in  terms  of  complications  our  results  are  comparable
o  the  ones  published  in  the  literature.
The  Dutch  Stent-In  2  trial14 suggested  an  association
etween  stent  perforation  and  recurrence.  In  this  trial,  a
otal  of  6/26  (23%)  perforations  were  recorded:  3  overt
nd  3  silent  perforations.  Recurrence  rate  was  83%  (5/6)
n  the  group  of  patients  with  stent-related  perforation  and
0%  (8/20)  in  the  group  without  perforation.  The  4-year
isease-free  survival  was  worse  in  the  former  group  (0%
s  45%,  p  = 0.007).  Although  the  numbers  are  strikingly  dif-
erent  between  the  perforated  and  non-perforated  groups,
he  authors  were  unable  to  draw  conclusions  due  to  the
mall  sample  size.  Recently  published  ESGE  guidelines  were
robably  based  on  the  fact  that  since  there  is  no  reduc-
ion  in  postoperative  mortality  after  SEMS  placement  as bridge  to  surgery11 and  oncological  outcome  of  poten-
ially  curable  patients  can  be  compromised  with  colonic
tenting,14 emergent  surgery  should  be  considered  as  the
p
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referred  treatment  strategy  for  patients  without  signiﬁcan-
ly  increased  operative  risk  (ASA  <  III  and/or  age  ≤  70  years).3
n  the  other  hand,  in  patients  with  an  increased  risk  of
ostoperative  mortality,  stent  placement  may  be  the  pre-
erred  treatment  since  the  potentially  impaired  oncological
utcome  associated  to  stent-related  perforation  seems  to
e  less  important  than  the  increased  risk  of  postoperative
eath.3
These  recommendations  were  perceived  by  most  gas-
roenterologists  and  colorectal  surgeons  as  being  very
onservative  and  unjustiﬁed.  As  some  heterogeneity  was
bserved  in  the  Dutch  trial,12 most  of  clinicians  involved
elt  that  if  these  studies  had  been  performed  in  well  trained
nd  high  volume  centers  this  rate  of  perforation  and  late
ecurrence  would  not  have  occurred.
In  our  study,  13  of  27  patients  who  underwent  stent
lacement  as  bridge  to  surgery  had  an  increased  risk  of
ostoperative  mortality  (ASA  ≥  III  and/or  age  >  70  years).
ourteen  patients  were  ≤70  years  and/or  ASA  <  III  and  4  out
f  6  perforations  were  observed  in  this  group.  Fortunately,
o  far  none  of  the  patients  with  stent-related  perforation
ad  recurrence.  Mean  follow-up  time  was  short  (14.7  ±  10.9
onths)  and  it  is  worth  noting  that  14  patients  still  have
 follow-up  time  lower  than  12  months.  Thus,  considering
revious  studies  namely  the  Dutch  Stent-In  2  trial,14 these
atients  should  be  kept  under  close  surveillance  before  any
eﬁnitive  conclusions  are  drawn.
Our  study  has  some  limitations,  namely  its  retrospec-
ive  nature,  the  small  sample  size  and  the  short  follow-up
ime  which  may  limit  our  conclusions  in  terms  of  onco-
ogic  outcome.  Nonetheless,  it  reﬂects  real  life  practice  and
t  was  reassuring  to  observe  that,  although  complications
amely  perforation  rates  are  within  those  described  in  the
iterature,  none  of  the  recurrences  observed  so  far  were
n  patients  in  whom  perforations  occurred.  Now  that  ESGE
uidelines  have  changed  and  colonic  stenting  is  no  longer
ecommended  as  a bridge  to  surgery  in  all  patients,  it  is
mportant  to  call  the  attention  of  endoscopists  that  oncolog-
cal  outcome  may  be  compromised  by  this  practice.  It  is  also
orth  noting  that  endoscopists  may  not  be  aware  of  silent
erforations  which  are  far  more  frequent  than  overt  ones
nd  which  may  very  well  increase  rate  of  local  or  distant
elapse.  In  fact,  if  not  all  patients  are  discussed  in  mul-
idisciplinary  meetings  both  pre  and  post-operatively,  we
elieve  that  most  gastroenterologists  will  not  be  aware  of
hese  silent  perforations.
. Conclusion
n  this  study,  SEMS  placement  was  an  effective  procedure
n  obstructive  CRC.  Because  ESGE  guidelines  changed  within
he  last  year,  colonic  stenting  was  mainly  used  as  a  bridge
o  elective  surgery.  However,  a  signiﬁcant  (22%)  rate  of
acro  and  microscopic  perforation  was  observed,  which
ight  increase  recurrence  rate  and  compromise  oncologi-atients  in  whom  perforation  was  not  observed.  A  prospec-
ive  registry  of  all  these  complications  should  be  mandatory
n  all  endoscopy  units.
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